Managing inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may soon become more advanced and ...

Upadacitinib may offer superior disease management than tofacitinib for patients with ulcerative colitis. Learn more.

Opens in a new tab or window ORLANDO -- Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes ...

Nutrients specific to the Mediterranean diet could help with symptom management in inflammatory bowel disease, evidence ...

Topline Clinical Data Demonstrates Activity of SOR102 Across Multiple Clinical Endpoints Supporting Advancement to Phase 2 ...

Researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically ...

The top gastroenterology biosimilar news from 2024 highlight fluctuations in the adalimumab biosimilar market throughout the ...

Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...

Discover how β-ionone offers relief from ulcerative colitis by enhancing gut health, reducing inflammation, and restoring ...

The search for effective therapies in ulcerative colitis, a chronic inflammatory condition affecting the colon and rectum ...

Understanding current trends in the incidence, prevalence, and distribution of ulcerative colitis can help inform diagnosis and treatment.